Notice: Users may be experiencing issues with displaying some pages on stanfordhealthcare.org. We are working closely with our technical teams to resolve the issue as quickly as possible. Thank you for your patience.

COVID-19 Updates: COVID-19 Resources » Vaccine Update » Updated Visitor Policy » What We're Doing to Keep You Safe »

Cutaneous T-Cell Lymphoma

Cutaneous lymphomas are a rare group of non-Hodgkin's lymphomas that begin in the skin as an itchy, red rash. The rash can thicken or form a tumor. The most common types are:

Mycosis fungoides
Sézary syndrome

Learn more about cutaneous lymphoma or learn about treatment options at our Skin Cancer Program.

INTERESTED IN AN ONLINE SECOND OPINION?

The Stanford Medicine Online Second Opinion program offers you easy access to our world-class doctors. It’s all done remotely and you don’t have to visit our hospital or one of our clinics for this service. You don’t even need to leave home!

Visit our online second opinion page to learn more.

Condition Spotlight

Press Release Skin Cancer Screening a Valuable Tool against Disease Watch Video

Keeping Close Watch Can Catch Skin Cancer Early Play Video | 3:18

Stanford Hospital's Dr. Kevin Wang Discusses Skin Cancer Prevention and Treatment Play Video | 1:12:57

Your Questions Answered: Skin Cancer Watch Video

Dr. Susan Swetter on Melanoma, the Most Deadly Form of Skin Cancer Watch Video

Clinical Trials

Clinical trials are research studies that evaluate a new medical approach, device, drug, or other treatment. As a Stanford Health Care patient, you may have access to the latest, advanced clinical trials.

Open trials refer to studies currently accepting participants. Closed trials are not currently enrolling, but may open in the future.

Open Trials Closed Trials

A Study of NKTR-214 Combined With Nivolumab vs Nivolumab Alone in Participants With Previously Untreated Inoperable or Metastatic Melanoma Melanoma, Skin Cancer

Mogamulizumab + Low-Dose Total Skin Electron Beam Tx in Mycosis Fungoides & Sézary Syndrome Skin Cancer

Pembrolizumab Compared to Standard of Care Observation in Treating Patients With Completely Resected Stage I-III Merkel Cell Cancer, STAMP Study Skin Cancer

Testing the Combination of Two Experimental Drugs MK-3475 (Pembrolizumab) and Interferon-gamma for the Treatment of Mycosis Fungoides and Sézary Syndrome and Advanced Synovial Sarcoma Cancer, Lymphoma,

Other Clinics

Stanford Cancer Center South Bay
833-444-7622

New to MyHealth?

ALREADY HAVE AN ACCESS CODE?

DON'T HAVE AN ACCESS CODE?

NEED MORE DETAILS?

MyHealth for Mobile

Cutaneous T-Cell Lymphoma